PML and B-cell non-Hodgkin lymphoma: Furthermore, UBE3A haploinsufficiency in an MYC-driven B-cell lymphomagenesis model increased PML levels, induced cellular senescence, and suppressed tumor progression, which is consistent with elevated levels of UBE3A and decreased levels of PML in primary B-cell lymphoma samples [230].